Objective: Few studies have explored Australian women's understandings of contraception. This study examined the attitudes towards, and understandings of, the subdermal contraceptive implant expressed by women living in New South Wales (NSW), Australia.

Study Design: As part of a larger qualitative study using in-depth, open-ended interviews in 2012-2013 with women aged 16-49 years who had ever used contraception (=94), 65 interviews from women who discussed or mentioned the subdermal implant, but had not previously used the device, were examined and analysed using thematic analysis.

Results: The emergent themes were: satisfaction with current method; weak personal opinions and ambivalence; uncertainty due to specific concerns; and strong negative reactions - fear and dislike. Although there were a few positive perceptions expressed by women who had never used the subdermal implant, for the majority of women the perception was predominantly negative.

Discussion And Conclusion: Women tended to form negative impressions from the stories of other women about the subdermal implant. Interventions to enhance evidence-informed awareness of the relative advantages and disadvantages of the implant - for example, improved access to supportive contraceptive counselling - need investigation in the Australian context. Avenues to improve women's perceived control over the device could also be usefully investigated.

Download full-text PDF

Source
http://dx.doi.org/10.1136/jfprhc-2014-101132DOI Listing

Publication Analysis

Top Keywords

subdermal implant
12
australian women's
8
attitudes understandings
8
understandings subdermal
8
subdermal contraceptive
8
contraceptive implant
8
qualitative study
8
expressed women
8
women subdermal
8
women
7

Similar Publications

Objective: To analyse the understanding of deaf women regarding contraceptive methods.

Method: We conducted a qualitative descriptive study in two referral centres for sexual and reproductive health (SRH) in São Paulo, Brazil, trough years 2020-2022. Twenty-eight deaf women who use Brazilian Sign Language (LIBRAS) were interviewed face-to-face and remotely via videocall using a semi-structured questionnaire containing sociodemographic and clinical data and questions about understanding and knowledge of contraceptive methods.

View Article and Find Full Text PDF

Background: The necessity for extended drug discharge to alleviate pain without adverse effects underscores the importance of innovative drug delivery systems. Achieving sustained pain relief without compromising patient safety is a critical objective in healthcare. By extending the duration of drug action while suppressing side effects, such systems offer enhanced therapeutic outcomes and improved patient quality of life.

View Article and Find Full Text PDF

Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices.

Hematology Am Soc Hematol Educ Program

December 2024

Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Hormonal contraceptive therapy (estrogens and/or progestogens) includes different formulations associated with varying venous thromboembolism (VTE) risks. The thrombogenicity of combined hormonal contraceptives (CHCs) is due at least in part to multiple changes in clotting factors and the vasculature and is dependent on both estrogen dose and type of progestin. Transdermal patch and vaginal ring users have similar or higher VTE risk as combined oral contraceptive users.

View Article and Find Full Text PDF
Article Synopsis
  • Reductions in estrogen can lead to cognitive decline by impairing mitochondrial function in the hippocampus, particularly affecting the entorhinal cortex.
  • Female rats underwent various procedures to assess the impact of estrogen deficiency, with findings showing that mitochondrial respiration decreased four weeks after ovariectomy but was maintained with estrogen supplementation.
  • The study revealed that the absence of estrogen leads to oxidative stress and reduced expression of important mitochondrial and synaptic proteins, suggesting a connection between low estrogen levels and declining cognitive functions.
View Article and Find Full Text PDF
Article Synopsis
  • Contraceptive arm implants are long-acting birth control devices placed under the skin of the upper arm, with two main types: etonogestrel (ENG) and levonorgestrel (LNG) releasing.
  • These implants are not biodegradable and must be removed after their licensed duration, either through a small incision if palpable or with imaging techniques if not.
  • Ultrasound is the preferred method for locating non-palpable implants, with additional options like X-ray and MRI used for more complex cases; an algorithm is provided for approaching implant localization based on specific circumstances.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!